FIGO recognises the urgent need for safe and effective preventive measures against epithelial ovarian cancer—one of the most ...

This year’s theme focuses on Menopause and Menopause Hormone Therapy (MHT), also known as Hormone Replacement Therapy (HRT), ...

We are delighted to celebrate that the EngenderHealth-led consortium FIGO is part of has been awarded a $89 million USAID ...

As FIGO president from 1991 to 1994 and editor of the International Journal of Gynecology and Obstetrics (IJGO) from 1985 to ...

The International Journal of Gynecology & Obstetrics (IJGO) has published the compelling new editorial ‘Beyond borders: The ...

The deadline to submit your proposal is Friday 1 November 2024. To submit your scientific session or Pre-Congress workshop, ...

The project in Rwanda Society of Obstetricians and Gynecologists (RSOG) has now concluded, but its impact endures through the ...

Since 2019, the Advocating for Safe Abortion project has empowered many national societies of obstetrics and gynaecology to ...

Limited access to high quality prenatal care, skilled birth attendants and emergency obstetric services substantially contributes to elevated rates of maternal deaths and disease, as well as adverse ...

In early 2020, FIGO began to develop a series of free webinars, with the aim of bringing together the global community of women's health experts, advocates, early-career and frontline health ...

May 2019, FIGO released Guidelines to combat pre-eclampsia, and calls for all women to receive first-trimester screening. Read the Pre-eclampsia Guidelines here. 76,000 women and 500,000 babies die ...

The Committee on Menstrual Disorders and Related Health Impacts focuses on the set of symptoms described as non-gestational abnormal uterine bleeding (AUB), including heavy menstrual bleeding (HMB).